References

References:

  1. McHugh KE, Stelow EB, Harrison GP, Policarpio-Nicolas MLC. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology. Cancer Cytopathology. 2019 Nov;127(11):700-707.
  2. Terris B, Cavard C. Diagnosis and molecular aspects of solid-pseudopapillary neoplasms of the pancreas. Semin Diagn Pathol. 2014 Nov;31(6):484-490.
  3. Hooper K, Tracht JM, Eldin-Eltoum IA. Cytologic criteria to reduce error in EUS-FNA of solid pseudopapillary neoplasms of the pancreas. J Am Soc Cytopathol. 2017 Nov-Dec;6(6):228-235.
  4. Pitman MB. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Arch Pathol Lab Med. 2024 Jan 8. doi: 10.5858/arpa.2023-0411-RA. Online ahead of print.
  5. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002 Apr;160(4):1361-9.